The anti-tumour activity of 6-azauracil riboside.

Experientia ·Vol. 14 ·No. 6 ·1958-06-15 ·Pages 215

SORM F, KEILOVA H

Abstract

暂无摘要

Keywords

CYTOTOXIC DRUGS NUCLEOSIDES AND NUCLEOTIDES/effects

MeSH Terms

Antineoplastic Agents Humans Neoplasms Nucleosides Nucleotides/pharmacology Uracil

Chemicals

Antineoplastic Agents Nucleosides Nucleotides Uracil azauracil

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

SORM F

KEILOVA H

References (6)

6 references, click to expand

The anticancerous action of 6-azauracil (3, 5-dioxo-2, 3, 4, 5-tetrahydro-1, 2, 4-triazine).
Experientia. 1956 Jul 15;12(7):271-2 PMID: 13344447
Microbial studies of 6-azauracil, an antagonist of uracil.
Cancer Res. 1956 Nov;16(10 Part 1):965-9 PMID: 13374706
Studies of bacterial resistance to 6-azauracil and its riboside.
Biochim Biophys Acta. 1957 Feb;23(2):428-30 PMID: 13412741
Potentiation of the antitumorous action of 6-azauracil by procaine and excretion of 6-azauracil from the body.
Neoplasma. 1957;4(3):204-7 PMID: 13504364
Antitumorous action of 6-azauracil on some transplantable experimental tumours.
Neoplasma. 1957;4(2):113-7 PMID: 13464885
The biosynthesis of 6-azauracil riboside by Escherichia coli growing in the presence of 6-azauracil.
Experientia. 1957 Apr 15;13(4):150-1 PMID: 13447904

Article Info

Journal

Experientia

Abbr.

Experientia

ISSN

0014-4754

DOI

Published

1958-06-15

Pages

215

Language

English

Region

Switzerland

NLM ID

0376547

Subset

External Links

Analysis Services